Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis

Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis

Objectives. The primary aim of our study was to evaluate long-term efficacy of secukinumab (SCK) in patients with axial spondyloarthritis (axSpA); secondary aims were to evaluate drug retention rate and to identify differences in the clinical and laboratory assessment according to axSpA clinical fea...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefano Gentileschi, Donato Rigante, Jurgen Sota, Giuseppe Lopalco, Maria Grazia Giannotta, Giacomo Emmi, Gerardo Di Scala, Florenzo Iannone, Claudia Fabiani, Bruno Frediani, Luca Cantarini
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/6983272
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items